ATE98121T1 - Fettsaeuren zur behandlung und praevention von hautschaeden durch radiotherapie. - Google Patents

Fettsaeuren zur behandlung und praevention von hautschaeden durch radiotherapie.

Info

Publication number: ATE98121T1
Authority: AT; Austria
Prior art keywords: skin damage; radiotherapy; prevention; treatment; fatty acids
Prior art date: 1989-09-07

Application number

AT90309638T

Other languages

English (en)

Inventor

David Frederick Horrobin

Catherine Ann Scott

Original Assignee

Scotia Holdings Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-09-07

Filing date

1990-09-04

Publication date

1993-12-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10662681&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE98121(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1990-09-04 Application filed by Scotia Holdings Plc filed Critical Scotia Holdings Plc

1993-12-15 Application granted granted Critical

1993-12-15 Publication of ATE98121T1 publication Critical patent/ATE98121T1/de

Links

238000001959 radiotherapy Methods 0.000 title abstract 2
230000037380 skin damage Effects 0.000 title abstract 2
235000014113 dietary fatty acids Nutrition 0.000 title 1
229930195729 fatty acid Natural products 0.000 title 1
239000000194 fatty acid Substances 0.000 title 1
150000004665 fatty acids Chemical class 0.000 title 1
230000002265 prevention Effects 0.000 title 1
HOBAELRKJCKHQD-UHFFFAOYSA-N (8Z,11Z,14Z)-8,11,14-eicosatrienoic acid Natural products CCCCCC=CCC=CCC=CCCCCCCC(O)=O HOBAELRKJCKHQD-UHFFFAOYSA-N 0.000 abstract 2
HOBAELRKJCKHQD-QNEBEIHSSA-N dihomo-γ-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCCCC(O)=O HOBAELRKJCKHQD-QNEBEIHSSA-N 0.000 abstract 2
239000003814 drug Substances 0.000 abstract 2
235000020664 gamma-linolenic acid Nutrition 0.000 abstract 2
VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 abstract 2
OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 abstract 1
235000021298 Dihomo-γ-linolenic acid Nutrition 0.000 abstract 1
239000003085 diluting agent Substances 0.000 abstract 1
239000003937 drug carrier Substances 0.000 abstract 1
VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 abstract 1
229960002733 gamolenic acid Drugs 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Toxicology (AREA)
Dermatology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Amplifiers (AREA)
Bipolar Transistors (AREA)
Junction Field-Effect Transistors (AREA)

AT90309638T 1989-09-07 1990-09-04 Fettsaeuren zur behandlung und praevention von hautschaeden durch radiotherapie. ATE98121T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB898920228A GB8920228D0 (en)	1989-09-07	1989-09-07	Fatty acid therapy

Publications (1)

Publication Number	Publication Date
ATE98121T1 true ATE98121T1 (de)	1993-12-15

Family

ID=10662681

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT90309638T ATE98121T1 (de)	1989-09-07	1990-09-04	Fettsaeuren zur behandlung und praevention von hautschaeden durch radiotherapie.

Country Status (14)

Country	Link
EP (1)	EP0416855B1 (de)
JP (1)	JPH0399013A (de)
KR (1)	KR910005858A (de)
AT (1)	ATE98121T1 (de)
AU (1)	AU633618B2 (de)
CA (1)	CA2024724A1 (de)
DE (1)	DE69005062T2 (de)
DK (1)	DK0416855T3 (de)
FI (1)	FI904403A7 (de)
GB (1)	GB8920228D0 (de)
HK (1)	HK74694A (de)
IE (1)	IE63449B1 (de)
NZ (1)	NZ235203A (de)
ZA (1)	ZA907040B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9301446D0 (en) *	1993-01-26	1993-03-17	Scotia Holdings Plc	Internal radiation damage
CA2119000A1 (en) *	1993-03-19	1994-09-20	David Frederick Horrobin	Formulation for use in smokers
AU711482B2 (en) *	1994-06-28	1999-10-14	Scotia Holdings Plc	Compositions for treatment of diabetic complications
US5690947A (en) *	1996-08-30	1997-11-25	Chesebrough-Pond's Usa Co., Division Of Conopco, Inc.	Borage seed oil as an anti-irritant in compositions containing hydroxy acids or retinoids
GB9621373D0 (en) *	1996-10-14	1996-12-04	Scotia Holdings Plc	Fatty acid treatment
PL334840A1 (en) *	1997-01-24	2000-03-27	Univ California	Application of fxr, pparalpha and lxralpha activators in order to restore the barrier function, to stimulate epithelium differentation and to inhibit proliferation
US5855893A (en) *	1997-02-14	1999-01-05	Elizabeth Arden Co., Division Of Conopco, Inc.	Trichodesma lanicum seed extract as an anti-irritant in compositions containing hydroxy acids or retinoids
FR2765482B1 (fr) *	1997-07-07	2000-12-08	Oreal	Utilisation de l'acide y-linolenique pour prevenir le stress oxydatif
GB9724802D0 (en) *	1997-11-24	1998-01-21	Unilever Plc	Antiperspirant or deodorant compoistions
CA2436650A1 (en)	2003-08-06	2005-02-06	Naturia Inc.	Conjugated linolenic acid (clnatm) compositions: synthesis, purification and uses
WO2006085687A1 (ja)	2005-02-14	2006-08-17	Suntory Limited	ジホモ−γ−リノレン酸（ＤＧＬＡ）を有効成分として含んで成る組成物
GB0907413D0 (en)	2009-04-29	2009-06-10	Equateq Ltd	Novel methods
US8293790B2 (en)	2011-10-19	2012-10-23	Dignity Sciences Limited	Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof
RU2714323C2 (ru)	2014-06-04	2020-02-14	ДиЭс БАЙОФАРМА ЛИМИТЕД	Фармацевтические композиции, содержащие дглк, и их применение
US20210315851A1 (en)	2020-04-03	2021-10-14	Afimmune Limited	Compositions comprising 15-hepe and methods of treating or preventing hematologic disorders, and/or related diseases
EP4658259A1 (de) *	2023-01-30	2025-12-10	Cold Spring Harbor Laboratory	Verwendung von arachidonsäure zur verbesserung der zytotoxischen wirkungen von chemotherapie und strahlentherapie

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ205076A (en) *	1982-08-09	1985-04-30	Univ California	Protecting and healing gastro-duodenal mucosa and the liver of mammals using a fatty acid
GB8302708D0 (en) *	1983-02-01	1983-03-02	Efamol Ltd	Pharmaceutical and dietary composition
US4851431A (en) *	1986-11-26	1989-07-25	Bar Ilan University	Physiologically active and nutritional composition
EP0309086A1 (de) *	1987-09-07	1989-03-29	Efamol Holdings Plc	Behandlung der männlichen Glatze und von unerwünschtem Haarwuchs
GB8806737D0 (en) *	1988-03-22	1988-04-20	Efamol Holdings	Therapeutic composition & method
GB8918294D0 (en) *	1989-08-10	1989-09-20	Efamol Holdings	Pharmaceutical compositions

1989
- 1989-09-07 GB GB898920228A patent/GB8920228D0/en active Pending
1990
- 1990-09-04 ZA ZA907040A patent/ZA907040B/xx unknown
- 1990-09-04 AU AU62135/90A patent/AU633618B2/en not_active Ceased
- 1990-09-04 EP EP90309638A patent/EP0416855B1/de not_active Revoked
- 1990-09-04 DK DK90309638.6T patent/DK0416855T3/da active
- 1990-09-04 DE DE90309638T patent/DE69005062T2/de not_active Revoked
- 1990-09-04 AT AT90309638T patent/ATE98121T1/de not_active IP Right Cessation
- 1990-09-05 IE IE322190A patent/IE63449B1/en not_active IP Right Cessation
- 1990-09-06 CA CA002024724A patent/CA2024724A1/en not_active Abandoned
- 1990-09-06 JP JP2234637A patent/JPH0399013A/ja active Pending
- 1990-09-06 FI FI904403A patent/FI904403A7/fi not_active Application Discontinuation
- 1990-09-06 NZ NZ235203A patent/NZ235203A/en unknown
- 1990-09-07 KR KR1019900014159A patent/KR910005858A/ko not_active Ceased
1994
- 1994-07-28 HK HK74694A patent/HK74694A/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
EP0416855A3 (en)	1991-06-12
CA2024724A1 (en)	1991-03-08
HK74694A (en)	1994-08-05
DE69005062T2 (de)	1994-05-05
AU6213590A (en)	1991-03-14
IE903221A1 (en)	1991-03-13
ZA907040B (en)	1991-06-26
IE63449B1 (en)	1995-04-19
DK0416855T3 (da)	1994-02-14
FI904403A0 (fi)	1990-09-06
DE69005062D1 (de)	1994-01-20
EP0416855A2 (de)	1991-03-13
JPH0399013A (ja)	1991-04-24
GB8920228D0 (en)	1989-10-18
NZ235203A (en)	1997-06-24
KR910005858A (ko)	1991-04-27
EP0416855B1 (de)	1993-12-08
AU633618B2 (en)	1993-02-04
FI904403A7 (fi)	1991-03-08

Similar Documents

Publication	Publication Date	Title
ATE98121T1 (de)	1993-12-15	Fettsaeuren zur behandlung und praevention von hautschaeden durch radiotherapie.
HUT65754A (en)	1994-07-28	Process for production of preparations containing complement inhibitors for treatment of inflammatory intestinal-and dermal-diseases
ATE73657T1 (de)	1992-04-15	Verwendung von gamma-linolensaeure und verwandten verbindungen zur herstellung eubnes arzneimittels zur behandlung von endometriose.
ATE163913T1 (de)	1998-03-15	Ungesättigte aliphatische dicarbonsäuren
DE69636085D1 (de)	2006-06-08	Verwendung von gamma-Linolensäure oder Dihomogammalinolensäure zur Herstellung eines Medikaments zur Behandlung von Huntington's Chorea
GR79989B (de)	1984-10-31
DE68917219D1 (de)	1994-09-08	Therapeutisches Erzeugnis zur Behandlung von Beschwerden während der oder nach den Wechseljahren.
ATE156015T1 (de)	1997-08-15	Arzneimittel zur behandlung von vulva-dystrophie oder vaginaltrockenheit
EP0502925A4 (en)	1992-12-16	Method and composition for treating inflammatory bowel disorders
DK0396184T3 (da)	1996-12-30	Anvendelse af ketoconazol og et retinoid til behandling af acne vulgaris
ATE99171T1 (de)	1994-01-15	Praeparate zur behandlung von beschwerden der wurzelhaut der zaehne.
ATE228835T1 (de)	2002-12-15	Verwendung von ranitidin-wismut-zitrat in kombination mit claritromyzin oder claritromyzin und tetrazyklin zur herstellung eines arzneimittels zur behandlung gastrointestinaler beschwerden
ATE120954T1 (de)	1995-04-15	Verwendung von essentiellen fettsäuren zur herstellung eines arzneimittels zur behandlung von aids.
ES2045120T4 (es)	1996-07-16	Metodo para preparar un medicamento para el tratamiento o la prevencion de la perdida de memoria.
ATE78696T1 (de)	1992-08-15	Arzneimittelzubereitung zur behandlung des immunmangels.
ATE60508T1 (de)	1991-02-15	Eisen enthaltende zusammensetzung und verfahren zur behandlung von krebs.
DE3685052D1 (de)	1992-06-04	Linolensaeuren enthaltende pharmazeutische und diaet-zusammensetzungen zur behandlung von gutartiger prostatahypertrophie.
ATE126056T1 (de)	1995-08-15	Mittel zur behandlung von seniler demenz, gedächtnisstörungen und ähnlichen zuständen.
DK0409559T3 (da)	1995-03-27	Farmaceutisk og diætetisk anvendelse af fedtsyrer
EP0302481A3 (de)	1990-08-22	Verwendung von freien Fettsäuren zur Herstellung eines Arzneimittels zur Behandlung von Diabetes mellitus
DE3681656D1 (de)	1991-10-31	Verwendung von linol- oder linolensaeure-metaboliten zur behandlung vom praemenstruellen syndrom.
JPS51118841A (en)	1976-10-19	A drug for improving and treating clouding of consciousness
ATE69949T1 (de)	1991-12-15	Liposomen mit inhalativen allergenen zur behandlung von allergien, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
DE3784738D1 (de)	1993-04-15	Topische vorstufen von arzneimitteln zur behandlung von akne und hautkrankheiten.
DE68916777D1 (de)	1994-08-18	Verwendung von TNF zur Herstellung eines Arzneimittels zur Behandlung von Psoriasis.

Legal Events

Date	Code	Title
1994-08-15	UEP	Publication of translation of european patent specification
2000-06-15	REN	Ceased due to non-payment of the annual fee
2001-09-15	RZN	Patent revoked